4.6 Article

PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Therapeutic strategies to overcome cisplatin resistance in ovarian cancer

Mengdi Song et al.

Summary: This review discusses the chemotherapeutic drugs and phytochemicals developed to overcome cisplatin-resistance ovarian cancer (CROC), highlighting the significance of combination therapy and the use of a nanoparticle delivery system in reversing cisplatin resistance.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas

Jiarui Fang et al.

Summary: CCT4 is highly expressed in ESCC and is associated with poor prognosis. Silencing CCT4 increases oxidative stress and inhibits glycolysis in ESCC cells, leading to inhibition of cell proliferation and migration, promotion of apoptosis, and cell cycle arrest. CCT4 knockdown also enhances the sensitivity of ESCC cells to DDP by regulating the AMPK/AKT/Nrf2 signaling pathway and inhibiting glycolysis ability.

MOLECULAR CARCINOGENESIS (2022)

Article Oncology

PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1

Shuo Yu et al.

Summary: This study identified PDK4 as a key upregulated kinase in cisplatin-resistant lung adenocarcinoma cells, where its overexpression was directly linked to chemoresistance and enhanced tumor cell growth through the regulation of EPAS1 expression. High expression of PDK4 was also correlated with poor prognosis in patients with lung adenocarcinoma.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Cell Biology

Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer

Jiawen Yang et al.

Summary: This study demonstrates that cetuximab enhances the cytotoxic effect of RSL3 on KRAS mutant CRC cells by regulating the p38/Nrf2/HO-1 axis to promote ferroptosis. These findings suggest a potential strategy to overcome drug resistance in KRAS mutant colorectal cancer.

CELL DEATH & DISEASE (2021)

Review Cell Biology

miRNA interplay: mechanisms and consequences in cancer

Meredith Hill et al.

Summary: miRNAs can control mRNA expression and target non-coding RNAs, including long non-coding RNAs and other miRNAs. MiRNA:miRNA interaction is a form of self-regulation, with direct, indirect, and global interactions being the main modes. Understanding the self-regulation of miRNAs can help identify novel regulatory mechanisms associated with disease pathways.

DISEASE MODELS & MECHANISMS (2021)

Review Cell Biology

The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells

Edward V. Prochownik et al.

Summary: Pyruvate plays a central role in metabolism, influenced by various cell-intrinsic and extrinsic factors. It is at the crossroads of glycolysis and the tricarboxylic acid cycle, with its production and fate being regulated by factors such as cell type, redox state, nutrient levels, and vascular supply. Six pathways impact pyruvate content and utilization, including lactate dehydrogenase pathway, alanine pathway, pyruvate dehydrogenase complex pathway, pyruvate carboxylase reaction, malic enzyme pathway, and acetate biosynthetic pathway. The review explores the mechanisms controlling these pathways and how they work together to achieve optimal growth and metabolic harmony.
Review Biochemistry & Molecular Biology

MicroRNA-375: potential cancer suppressor and therapeutic drug

Jiahui Wei et al.

Summary: MiR-375, a conserved noncoding RNA, plays a crucial role in tumor cell proliferation, migration, and drug resistance. Studies have shown that it affects the epithelial-mesenchymal transition of tumor cells through key transcription factors and signaling pathways, making it vital for cancer development. Recent research has also identified microRNA delivery systems for enhanced in vivo transportation of miR-375.

BIOSCIENCE REPORTS (2021)

Article Oncology

Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression

Hongtao Liu et al.

Summary: Recent studies have shown that SLC2A1-AS1 may play a critical role in tumor development and progression in esophageal cancer patients by regulating glycolysis, and the SLC2A1-AS1/miR-378a-3p/Glut1 regulatory axis could be a novel therapeutic target for metabolic remodeling in esophageal cancer patients.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Review Oncology

Understanding and overcoming resistance to PARP inhibitors in cancer therapy

Mariana Paes Dias et al.

Summary: PARP inhibitors have shown success in treating certain cancer patients, but most will develop resistance to these inhibitors, prompting the need for novel treatment strategies. Current research efforts are focused on finding ways to overcome resistance mechanisms.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Cell Biology

DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism

Jing Du et al.

Summary: The combination of dihydroartemisinin (DHA) and cisplatin (DDP) synergistically enhances the cytotoxicity of pancreatic ductal adenocarcinoma (PDAC) cells by inducing ferroptosis. The impairment of mitochondrial homeostasis and the accumulation of free iron and lipid peroxidation contribute to the cytotoxic effects. Pharmacological manipulation of iron levels can modulate the sensitivity of PDAC cells to DHA/DDP-induced ferroptosis. These findings suggest a promising therapeutic strategy for PDAC treatment.

CELL DEATH & DISEASE (2021)

Review Biochemistry & Molecular Biology

MicroRNA-375: potential cancer suppressor and therapeutic drug

Jiahui Wei et al.

Summary: MiR-375 plays a crucial role in tumor cell proliferation, migration, and drug resistance by affecting key transcription factors and signaling pathways. Recent studies have shown the potential of miR-375 as a molecular biomarker and therapeutic target for improving the efficiency of clinical cancer diagnosis.

BIOSCIENCE REPORTS (2021)

Article Multidisciplinary Sciences

Prediction of miRNA targets by learning from interaction sequences

Xueming Zheng et al.

PLOS ONE (2020)

Review Multidisciplinary Sciences

Metabolic reprogramming and cancer progression

Brandon Faubert et al.

SCIENCE (2020)

Review Biology

The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression

Peter Vaupel et al.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)

Review Oncology

MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

Lu Zhang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Biochemistry & Molecular Biology

Cisplatin: The first metal based anticancer drug

Sumit Ghosh

BIOORGANIC CHEMISTRY (2019)

Review Oncology

MicroRNA-125 in immunity and cancer

Jessica K. Wang et al.

CANCER LETTERS (2019)

Review Oncology

Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis

Benjamin L. Woolbright et al.

MOLECULAR CANCER THERAPEUTICS (2019)

Article Medicine, Research & Experimental

Icariin modulates carrageenan-induced acute inflammation through HO-1/Nrf2 and NF-kB signaling pathways

Nagla A. El-Shitany et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Pharmacology & Pharmacy

PDK2 induces cisplatin-resistance in lung adenocarcinoma via transcriptional regulation of CNNM3

Tinghua Hu et al.

JOURNAL OF DRUG TARGETING (2019)

Article Oncology

Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma

Juan Lu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Article Biochemistry & Molecular Biology

Protein S-glutathionylation alters superoxide/hydrogen peroxide emission from pyruvate dehydrogenase complex

Marisa O'Brien et al.

FREE RADICAL BIOLOGY AND MEDICINE (2017)

Review Pharmacology & Pharmacy

Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1

Margaret O. James et al.

PHARMACOLOGY & THERAPEUTICS (2017)

Article Oncology

Oncogenic role of PDK4 in human colon cancer cells

D. Leclerc et al.

BRITISH JOURNAL OF CANCER (2017)

Review Biochemistry & Molecular Biology

Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism

Agnieszka Loboda et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

Article Pharmacology & Pharmacy

Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy

Helena Populo et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2015)

Editorial Material Gastroenterology & Hepatology

Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries

Maria Jose Domper Arnal et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)